![](https://investorshub.advfn.com/uicon/522650.png?cb=1464431304)
Friday, January 13, 2017 8:50:26 AM
You do realize Pfizer pays Purdue royalty fees for Embeda patent infringement rights don't you???
Pfizer isn't going to sue Elite - it doesn't have a leg to stand on. If anyone is going to sue Elite it is going to be Purdue.......but here's the funniest part..........Teva and Epic pharma screwed Purdue - LMAO!!!
Purdue could sue for royalties and Pfizer could sue for exclusivity. Any licensee or assignee of a patent has standing to sue for infringement. These two companies are in court so much they keep extra teams of lawyers in suspended animation in their basement storage lockers. They have an endless supply. Why wouldn't one or both sue? It's what they do and how the how the whole system works.
Nobody is going to pull one over on Elite - Purdue's main ADT patents were ruled to be invalid.
So BS on the whole Elite will be tied up in court for years.
I'm not aware of any successful challenges to the validity naltrexone subunit patent that is listed for both Embeda and Troxyca. Their hard shell ADF patents are invalidated as "obvious." Elite's argument is going to be that the antagonist ADF concept is "obvious" and the mechanism of sequestration is what can be patented. And Elite will win.
Besides Elite hired the previous FDA lead attorney. Good luck on that legal front. LMAO!!!
Pretty obvious Nasrat knows what is coming.
Historic note: Until his life's destiny was further clarified, Robin Hood spent several years robbing from the rich and giving to the porcupines. (G. Larson 7/26/82)
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM